MedTrace Logo

Caminamos: A Smartphone App for Latinas to Connect With Walking Partners

NCT03854916 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 78

Last updated 2023-07-14

Study results available
· View outcomes & findings →

Summary

Despite numerous interventions designed to increase physical activity, few are specifically tailored to Latinas, a population where higher rates of obesity, diabetes, and other chronic diseases are present. This proposed smartphone app, ¡Caminemos Juntas!, will use location-based services to connect Latinas with one another in order to improve walking habits by increasing social support and decreasing perceived barriers, both of which are known to play a role in physical activity behaviors. Through a randomized comparative-effectiveness trial, this Phase II project will test the effectiveness of a smartphone application for improving physical activity among Latinas when providing them with real-time opportunities to connect socially with the goal of walking.

Conditions

  • Physical Activity

Interventions

OTHER

Caminemos Juntas App

A tailored mobile app that encourages Latinas and Hispanic women to walk together using location-based services.

OTHER

World Walking App

A mobile app that encourages users to walk.

Sponsors & Collaborators

  • National Institute on Minority Health and Health Disparities (NIMHD)

    collaborator NIH

  • Stanford University

    collaborator OTHER

  • Klein Buendel, Inc.

    lead INDUSTRY

Principal Investigators

  • Valerie Myers, PhD · Senior Scientist

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
69 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-02-28
Primary Completion
2022-04-30
Completion
2022-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03854916 on ClinicalTrials.gov